Testing cholesterol at home: What a home test can tell you

You do not always need to visit a clinic to check your cholesterol. Some home tests report only total cholesterol; others provide several blood lipid measurements. Before buying one, check which results it provides, how the sample is collected, and whether help interpreting the results is included. A convenient test becomes much more useful when you know who will discuss it with you and what happens if a result is high.

How a home cholesterol test works

Many self-tests use a small drop of blood from a fingertip. A strip or meter reads the sample immediately, while a mail-in test sends it to a laboratory. Another option is a mobile professional who draws blood from a vein at home. That is a different kind of home testing and does not require you to prick your own finger.

High LDL cholesterol usually causes no clear symptoms. Testing can detect it before cardiovascular disease becomes apparent. How much a home test tells you depends largely on which parts of a lipid profile it actually measures.

Comparing the types of test

A complete lipid profile usually includes total cholesterol, HDL cholesterol, triglycerides, and either a measured or calculated LDL cholesterol result. Not every product offers all four.

Test type	Sample	Possible measurements	When you receive the result
Meter with test strips	Finger-stick blood	Total cholesterol, with additional lipid measurements on some models	On the meter
Color-changing test strip	Finger-stick blood	Often total cholesterol only	Read against a color scale
Mail-in test	Capillary sample, such as dried blood spots	Depends on the product and its validated method	After the laboratory receives and analyzes it
Directly arranged venous laboratory test	Blood from an arm vein, at a collection center or through a mobile service	A lipid profile, with other tests if ordered	After laboratory analysis

Ordering requirements and availability vary by state, country, and provider. Check whether the service can supply the required order and serve your location, rather than assuming that every advertised test is available everywhere.

What the individual numbers mean

Reference values are a starting point, not a personalized treatment plan. LDL and non-HDL goals depend on overall cardiovascular risk. Someone who already has cardiovascular disease may need substantially lower levels than someone without those risk factors.

Measurement	What it describes	Common adult reference point
Total cholesterol	Cholesterol carried in several types of lipoprotein combined	Below 200 mg/dL
LDL cholesterol	Cholesterol in LDL particles	Below 100 mg/dL is a general reference; individual treatment goals may be lower
HDL cholesterol	Cholesterol in HDL particles	Below 40 mg/dL in men or 50 mg/dL in women is commonly considered low
Triglycerides	Another type of blood fat	Below 150 mg/dL fasting or 175 mg/dL nonfasting
Non-HDL cholesterol	Total cholesterol minus HDL	Below 130 mg/dL is a general reference; risk-based goals may differ

For HDL, “higher is better” does not apply without limit. A level of at least 60 mg/dL has often been described as favorable, but it does not guarantee protection. Nor can a normal total cholesterol result cancel out other risk factors. The 2026 US dyslipidemia guideline emphasizes risk-based LDL and non-HDL goals rather than treating one general cutoff as right for everyone.

How accurate are home tests?

Accuracy varies between products and depends on correct use. In a study of five over-the-counter self-tests involving 62 adults, the mean absolute relative difference from laboratory cholesterol measurements ranged from about 6% to 20%. These were averages for the devices tested, not a guaranteed error range for every individual result or every current product. Kurstjens and colleagues found good performance from one meter but substantially poorer performance from several other tests. The best-performing total-cholesterol meter could not measure HDL, so accuracy and completeness are separate questions.

Devices used by professionals for capillary samples also differ. A 2025 rapid review of 22 studies covering six point-of-care devices found that evidence for two systems largely met the selected accuracy standards. Professional use in a studied setting does not automatically establish performance when someone uses another device alone at home. In the United States, you can check a product’s specific FDA clearance in public records; regulatory status does not make all testing methods interchangeable.

Squeezing the finger too hard can affect the sample. Storage, transport, and the amount of blood must also match the instructions. Meals particularly affect triglycerides. Routine lipid profiles do not always require fasting, although some tests call for nine to twelve hours without food. Follow the instructions for your particular test. The FDA explains how to use cholesterol self-tests and their limitations.

Benefits and limitations in everyday use

Home testing can save travel and appointment planning. For some people, that makes an initial check more accessible. Mail-in samples can also be useful when the laboratory method has been validated for that sample type.

A dried blood spot result is not automatically interchangeable with a venous serum result. Some studies use specific adjustments to make the measurements comparable. Those adjustments belong within the validated laboratory method, not in a formula you choose yourself. Research has found dried blood spot collection feasible for estimating population cardiovascular risk; that does not mean every commercial kit performs equally well for an individual treatment decision.

For many simple tests, the main limitation is that they report only total cholesterol. Two people can have the same total and very different LDL, HDL, or triglyceride levels. Check before ordering whether the service includes an explanation of the results and an appropriate follow-up plan.

What to do after a high home result

An unexpected result deserves interpretation. A complete lipid profile under appropriate conditions is often the next step. Discuss total cholesterol above 200 mg/dL with your healthcare professional, but do not treat that number alone as a decision about medication. Blood pressure, smoking, diabetes, family history, and existing disease also matter.

Lipoprotein(a), or Lp(a), can add information about inherited cardiovascular risk even when LDL is low. Current US guidance recommends measuring it at least once in adulthood. ApoB testing can be useful selectively to refine risk assessment. Neither recommendation means that everyone needs an extensive commercial test panel. The American Heart Association’s 2026 guideline overview summarizes these updates; it replaces the 2018 guideline listed in the references as historical background.

The following intervals are the general US screening guidance described by MedlinePlus, rather than a schedule specifically for home kits. Your risk factors and treatment can change the timing.

Group	General screening interval
Younger adults, starting at age 20	About every five years when more frequent testing is not indicated
Men ages 45–65	About every one to two years
Women ages 55–65	About every one to two years
Adults older than 65	About yearly

People receiving treatment or at higher risk may need a different schedule. Do not start, stop, or change prescribed medication solely because of a home test result.

Getting a result you can use

A useful test answers a clear question and comes with a plan for abnormal results. If you have previous lipid measurements, bring them to the discussion. Comparing them is easier when you know the sample type, units, and collection conditions. That turns an isolated number into information you can use for appropriate prevention.

References

MedlinePlus. Cholesterol levels. National Library of Medicine. Updated October 15, 2024. Accessed October 16, 2026. https://medlineplus.gov/lab-tests/cholesterol-levels/

National Heart, Lung, and Blood Institute. Blood cholesterol: symptoms. Updated April 18, 2024. Accessed October 16, 2026. https://www.nhlbi.nih.gov/health/blood-cholesterol/symptoms

National Heart, Lung, and Blood Institute. Blood cholesterol: diagnosis. Updated April 18, 2024. Accessed October 16, 2026. https://www.nhlbi.nih.gov/health/blood-cholesterol/diagnosis

US Food and Drug Administration. Home use tests: cholesterol. Content current as of February 4, 2018. Accessed October 16, 2026. https://www.fda.gov/medical-devices/home-use-tests/cholesterol

Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-1958. https://doi.org/10.1093/eurheartj/ehw152

Kurstjens S, Gemen E, Walk S, et al. Performance of commercially-available cholesterol self-tests. Ann Clin Biochem. 2021;58(4):289-296. https://doi.org/10.1177/0004563221992393

Mutepfa CC, Hicks TP, Winter A, et al. Can we trust published evidence on point-of-care tests for cholesterol? A rapid review. BMJ Open. 2025;15(3):e080726. https://doi.org/10.1136/bmjopen-2023-080726

US Food and Drug Administration. 510(k) premarket notification K072836: CholesTrak HDL Cholesterol Home Test. Decision date December 27, 2007. Accessed October 16, 2026. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K072836

Harvard Health Publishing. Cholesterol testing at home: it may be faster, but is it better? Published January 20, 2017. Accessed October 16, 2026. https://www.health.harvard.edu/heart-health/cholesterol-testing-at-home-it-may-be-faster-but-is-it-better

Greenland P, Bowley NL, Meiklejohn B, Doane KL, Sparks CE. Blood cholesterol concentration: fingerstick plasma vs venous serum sampling. Clin Chem. 1990;36(4):628-630.

Kumari M, Andrayas A, Al Baghal T, et al. A randomised study of nurse collected venous blood and self-collected dried blood spots for the assessment of cardiovascular risk factors in the Understanding Society Innovation Panel. Sci Rep. 2023;13(1):13008. https://doi.org/10.1038/s41598-023-39674-6

Affan ET, Praveen D, Chow CK, Neal BC. Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis. BMC Clin Pathol. 2014;14:21. https://doi.org/10.1186/1472-6890-14-21

Historical guideline, replaced in 2026: Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. https://doi.org/10.1161/CIR.0000000000000625

Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946. https://doi.org/10.1093/eurheartj/ehac361

American Heart Association (2026). 2026 Guideline on the Management of Dyslipidemia. https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia

Blumenthal RS, Morris PB, et al. 2026 ACC/AHA multisociety guideline on the management of dyslipidemia. Circulation. 2026;153:e1154–e1276. https://doi.org/10.1161/CIR.0000000000001423

Corrections to the 2026 guideline: Circulation. 2026;153:e1447. https://doi.org/10.1161/CIR.0000000000001457 ; 2026;154:e393. https://doi.org/10.1161/CIR.0000000000001475